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ABSTRACT
Objective: This study seeks to analyse the prevalence
and correlates of electronic cigarette (e-cigarette) use,
purchase location and satisfaction with its use in a
sample of the general population of the city of
Barcelona, Spain.
Design, setting and participants: We used
participants from a longitudinal study of a
representative sample of the adult (≥16 years old)
population of Barcelona (336 men and 400 women).
The field work was conducted between May 2013 and
February 2014. We computed the prevalence, adjusted
odds ratios (ORs) and their corresponding 95%
confidence interval (CI).
Results: The prevalence of ever e-cigarette use was
6.5% (95% CI 4.7% to 8.3%): 1.6% current use, 2.2%
past use and 2.7% only e-cigarette experimentation.
75% (95% CI 62.8% to 87.3%) of ever e-cigarette
users were current cigarette smokers at the moment of
the interview. E-cigarette use was more likely among
current smokers (OR=54.57; 95% CI 7.33 to 406.38)
and highly dependent cigarette smokers (OR=3.96;
95% CI 1.60 to 9.82). 62.5% of the ever users
charged their e-cigarettes with nicotine with 70% of
them obtaining the liquids with nicotine in a
specialised shop. 39.6% of ever e-cigarette users were
not satisfied with their use, a similar percentage of not
satisfied expressing the smokers (38.9%) and there
were no statistically significant differences in the
satisfaction between the users of e-cigarettes with and
without nicotine.
Conclusions: E-cigarette use is strongly associated
with current smoking (dual use) and most users
continue to be addicted to nicotine. Six out of 10
e-cigarette users preferred devices that deliver nicotine.
The satisfaction with e-cigarette use is very low.
INTRODUCTION
The electronic cigarette, also called
‘e-cigarette’ or electronic nicotine delivery
system, is an electronic device commonly
shaped like a cigarette. There are also
devices resembling cigars or pipes.
Regardless of their shape, they are designed
to vapourise a mixture of nicotine, propylene
glycol and other chemicals that heat the
vapour via a battery activated by pufﬁng, but
contain no actual tobacco.
12The device can
also vapourise a mixture that does not
contain nicotine. Interest in e-cigarettes has
been growing recently among smokers, man-
ufacturers, including leading tobacco com-
panies, and also among tobacco control
researchers and the public health commu-
nity in general, who are concerned with their
potential risks and cautiously optimistic
about their potential beneﬁts.
2 Interest in
e-cigarettes, as measured by internet
searches, exceeded that of snus or nicotine
replacement therapies.
3
Initially, e-cigarettes were primarily
obtained through internet sources. Specialty
shops and varieties of brands have grown
rapidly in recent years in several developed
countries. General awareness of e-cigarettes
has doubled in just 1 year in the USA.
4
However, scientiﬁc evidence concerning
Strengths and limitations of this study
▪ Scientific evidence concerning e-cigarettes is still
very limited, particularly in Europe.
▪ This is the first study to estimate the correlates
of use of e-cigarettes in a representative sample
of the general adult population in a
Mediterranean city.
▪ The main limitation of our study is attrition of
the cohort used, which could lead to a possible
no participation bias.
▪ This is a cross-sectional study and it is only pos-
sible to assess associations, but not causal
relationships.
▪ This is the first study that used a face-to-face
questionnaire with trained interviewers to assess
e-cigarette use in a representative sample of the
general population, thus potentially increasing
the internal validity of our results.
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of the prevalence of e-cigarette use among the general
population, particularly in Europe. Moreover, to our
knowledge, there is a lack of information on speciﬁc
characteristics of use, such as the location of purchase,
use of liquids containing nicotine and the satisfaction
with this product among users. These issues are espe-
cially relevant to characterise the use of this new
product in order to implement future regulations.
The objective of this study is to estimate the preva-
lence and analyse the correlates of current and ever use
of e-cigarettes, including purchase location and satisfac-
tion with its use, in a sample of the general population
of the city of Barcelona (Spain) in 2013 and 2014.
METHODS
The Determinants of Cotinine phase 3 project (dCOT3,
website: http://bioinfo.iconcologia.net/es/content/
estudio-dcot3) is a longitudinal study of a representative
sample of the adult (≥16 years old) non-institutionalised
population of the city of Barcelona (Spain; n=1245, 694
women and 551 men). The theoretical baseline sample
size was 1291 individuals, assuming an expected smoking
prevalence of 30% (with an α error of 5% and a preci-
sion of 2.5%), which was the estimated percentage of
smokers in Spain when the baseline survey was
conducted. The baseline survey was conducted in 2004–
2005 and its detailed design has been provided else-
where.
56We followed up all the adult participants who
responded to a face-to-face questionnaire in 2004–2005
and agreed to participate in future studies. At the begin-
ning of 2013, we did a linkage with the Insured Central
Registry of Catalonia in order to update the vital status
and contact information (addresses and telephone
numbers) of all participants. We restricted the follow-up
to the participants who continued to live in the city of
Barcelona and their province.
We traced 1010 people out of the 1245 participants in
the baseline study using the Insured Central Registry
(101 have died, 49 migrated out of the province of
Barcelona and 85 did not give consent to be followed or
were <18 years old in 2004–2005). In February 2013, we
sent them a letter stating the primary ﬁndings of the
2004–2005 study and informed them that an interviewer
would go to their home to administer another
face-to-face questionnaire. The follow-up survey was con-
ducted between May 2013 and February of 2014. In
total, 72.9% agreed to participate and responded to the
questionnaire, 18.5% refused to participate in the
follow-up, 7.2% had moved elsewhere and 1.3% had
died. The ﬁnal sample analysed was 736 individuals (336
men and 400 women). Although there were no statistic-
ally signiﬁcant differences between the followed up
sample and the participants lost according to age, sex,
level of education and smoking status, the ﬁnal sample
skewed as slighter older (data not shown).
Data on current use, ever use and experimentation
with e-cigarettes were obtained using the question (as
translated from Spanish): “Have you ever used
e-cigarettes?” The answers to this question were: “yes,
currently”; “yes, in the past”; “I have only experimented
with e-cigarettes”; and “I have never used e-cigarettes.”
We also included two questions about the use of
e-cigarettes with or without nicotine using the question:
“Do/did you use the electronic cigarettes with nicotine?”
(yes/no) and the places where the nicotine was
obtained (internet, specialised shop or other countries).
Finally, we asked ever e-cigarette users about their satis-
faction with e-cigarettes using the question: “How satis-
ﬁed are you with the use of the electronic cigarette?”
The possible answers for this question were: “totally satis-
ﬁed”; “quite satisﬁed”; “somewhat satisﬁed” and “not sat-
isﬁed” (recoded as “totally and quite satisﬁed,”
“somewhat” and “not satisﬁed”). We calculated the
prevalence and the adjusted odds ratios (ORs) with 95%
conﬁdence intervals (CIs) by sex, age and educational
level. All analyses were stratiﬁed by sex; groups of age
(≤44, 45–64 and ≥65 years old); educational level—cate-
gorised as low (no qualiﬁcation up to middle school
diploma), intermediate (high school) and high (univer-
sity degree); cigarette smoking status (current smokers
as participants who smoked cigarettes either daily (at
least one cigarette/day) or occasionally (less than one
cigarette/day) at the moment of the survey, former
smokers as participant who did not smoke cigarettes at
the moment of the survey but had smoked cigarettes in
the past and never-smokers as participants who have
never smoked cigarettes); and level of nicotine depend-
ence measured with the Fagerström test for cigarette
dependence (FTCD)
7 for current cigarette smokers, and
categorised into low-medium dependence for scores
between 0 and 5 and high dependence for scores
between 6 and 10.
RESULTS
The prevalence of smokers of manufactured cigarettes
was 23.3% (95% CI 20.2% to 26.3%) and the prevalence
of ever e-cigarette use was 6.5% (95% CI 4.7% to 8.3%).
Smokers of manufactured cigarettes had a mean age of
49.4 years, 53.8% were men and 47.9% had intermediate
educational level. The e-cigarette users had a mean age
of 45.1 years, 56.2% were men and 58.3% had inter-
mediate educational level. There were no statistically sig-
niﬁcant differences according to demographic
characteristics (sex, age, and level of education)
between smokers of manufactured cigarettes and
e-cigarette users. In total, 75% of e-cigarette users were
smokers, 22.9% were former smokers and 2.1% were
never-smokers at the time of the interview. The preva-
lence of ever e-cigarette use was higher among men
(8%), younger people (≤44 years old, 13.1%) and
people with intermediate educational level (9.8%,
OR=1.42, 95% CI 0.50 to 4.04). There was a statistically
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current smoking (OR=54.57, 95% CI 7.33 to 406.38).
Also, the highest prevalence (46.4%) of ever e-cigarette
use was among current smokers with a high cigarette
dependence score (table 1).
In total, 62.5% of ever e-cigarette users (95% CI
48.8% to 76.2%) used them with nicotine and 70%
(95% CI 53.6% to 86.4%) indicated they obtained the
liquid with nicotine in a specialty shop, while 3.3%
(95% CI 0.6% to 16.7%) indicated that they obtained it
on the internet. There were no statistically signiﬁcant
differences according to sex, age, educational level and
smoking status regarding the use of e-cigarettes with
nicotine or not (table 1), and the places where they
obtained the liquid with nicotine (data not shown).
Among ever e-cigarette users, 18.8% (95% CI 7.7% to
29.9%) were totally or quite satisﬁed with their use and
39.6% (95% CI 25.8% to 53.4%) were not satisﬁed. The
percentage of not satisﬁed users was 38.9% among
current smokers, 30.8% among smokers with high cigar-
ette dependence score (table 1). There were no statistic-
ally signiﬁcant differences in the satisfaction with
e-cigarettes according to use of liquids with and without
nicotine (not satisﬁed: 40% vs 38.9%; OR=0.53, 95% CI
0.11 to 2.49).
Table 2 shows the prevalence rates of current use, past
use and only experimentation with e-cigarettes. In total,
1.6% were current users, 2.2% past users and 2.7% had
only experimented with e-cigarettes. There were no stat-
istically signiﬁcant differences among current e-cigarette
users according to sex, age and educational level.
Finally, the prevalence of current use was higher among
current smokers (dual users) and among current
smokers with high cigarette dependence score (5.3%
and 14.3%, respectively).
DISCUSSION
This is the ﬁrst study to estimate the use of e-cigarettes
in a representative sample of the general adult popula-
tion in a Mediterranean city. The prevalence of ever
e-cigarette use was 6.5% (1.6% current use, 2.2% past
use and 2.7% only e-cigarette experimentation) and the
predominant ever and current e-cigarette use was
among current smokers (75% of ever e-cigarette users
were current smokers). Similar results were found for
the general population in Europe according to the
Eurobarometer survey conducted in 2012
8 and also in
the USA
9 according to a study conducted in 2010–2011.
Surprisingly, our prevalence of ever use is lower to what
we would expect, considering the increase of marketing
and popularity of e-cigarettes in recent years. This low
prevalence could be due to a potential delay in the
general marketing of e-cigarettes in Spain as compared
Table 1 Prevalence of ever e-cigarette use, percentage of users of e-cigarettes with cotinine, and percentage of satisfaction
with e-cigarettes according to sex, age, educational level, smoking status and FTCD in Barcelona, Spain (2013–14).
Ever e-cigarette users
Ever use of e-cigarettes
with nicotine
Satisfaction with the
usage of e-cigarettes
(not satisfied)
n % OR* (95% CI) n %† OR* (95% CI) %† OR* (95% CI)
Overall 736 6.5 48 62.5 39.6
Sex
Men 336 8.0 1 27 51.9 1 44.4 1
Women 400 5.3 0.69 (0.38 to 1.27) 21 76.2 2.66 (0.62 to 11.32) 33.3 0.49 (0.11 to 2.26)
Age (years)
≤44 198 13.1 1 26 73.1 1 30.8 1
45–64 267 6.7 0.39 (0.20 to 0.75) 18 44.4 0.32 (0.08 to 1.28) 55.6 3.21 (0.78 to 13.13)
≥65 271 1.5 0.08 (0.02 to 0.24) 4 75.0 1.49 (0.13 to 17.48) 25.0 0.73 (0.05 to 10.84)
Educational level
Low 161 3.1 1 5 60.0 1 0.0 –
Intermediate 287 9.8 1.42 (0.50 to 4.04) 28 53.6 1.56 (0.18 to 13.05) 42.9 1
High 288 5.2 0.49 (0.16 to 1.53) 15 80.0 2.64 (0.27 to 26.15) 46.7 2.41 (0.48 to 12.15)
Smoking status
Never-smoker 298 0.3 1 1 0.0 – 0.0 –
Former smoker 267 4.1 13.19 (1.68 to 103.82) 11 54.5 1 45.5 1
Current smoker 171 21.1 54.57 (7.33 to 406.38) 36 66.7 1.22 (0.21 to 6.92) 38.9 1.30 (0.28 to 5.96)
FTCD
Low-Medium (0–5) 143 16.1 1 23 60.9 1 43.5 1
High (6–10) 28 46.4 3.96 (1.60 to 9.82) 13 76.9 5.86 (0.73 to 46.77) 30.8 0.14 (0.01 to 1.42)
*Adjusted ORs for sex, age and educational level.
†Prevalence among ever e-cigarette users.
FTCD, Fagerström test for cigarette dependence.
OR, odds ratio; CI, confidence intervals.
Martínez-Sánchez JM, et al. BMJ Open 2014;4:e005894. doi:10.1136/bmjopen-2014-005894 3
Open Accesswith other countries, as well as the quick reaction of the
tobacco control community and public health author-
ities to apply the precautionary principle in Spain.
10 We
also found that 62.5% of the ever e-cigarette users
preferred liquids with nicotine and specialty shops were
the places where they most frequently bought these
liquids (70%).
One study conducted among young Swiss men showed
lower prevalence of ever e-cigarette use in the past
12 months than in our study (4.9%).
11 A study con-
ducted among teenagers from Poland (between 15 and
24 years old) showed that 6.9% of them reported experi-
menting with e-cigarettes in the previous 30 days
12 while
we found 13.1% of ever e-cigarette use among young
people (≤44 years old). Another study conducted in the
UK, using telephone interviews among current and
former smokers,
13 showed that 4% were current
e-cigarette users and, among those who were aware of
e-cigarettes, 17.7% had tried e-cigarettes, which is
slightly lower than in our study (5.3% and 21.1%,
respectively). However, the differences in the questions
used to measure the prevalence of e-cigarette use make
the comparison among studies difﬁcult.
Currently, there is an intense debate in the tobacco
control community about the usefulness of e-cigarettes as
a new strategy to quit or reduce tobacco consumption
and its potential harmful health effects.
14–22 The only
clinical trial published to date
23 showed that 7.3% of
those who used e-cigarettes with nicotine to quit smoking
were still abstinent at 6 months, compared with 5.8% who
used nicotine patches and to 4.1% who used e-cigarettes
without nicotine, although no statistically signiﬁcant dif-
ferences were found. Two longitudinal studies
24 25 also
found that e-cigarettes may contribute to preventing
relapse in former smokers and to promote smoking cessa-
tion in current smokers. Other studies
492 6suggest that
there is a high percentage of e-cigarette users concur-
rently using conventional tobacco. However, the evidence
is still scarce according to recent reviews of the scientiﬁc
literature.
27 28 According to our data, we likewise found a
high percentage (75%) of current e-cigarette users exhi-
biting dual use patterns with conventional tobacco.
Moreover, we surprisingly found a very low percentage of
ever e-cigarette users quite or totally satisﬁed with their
use (18.8%), particularly among current smokers and
smokers with a high score in the FTCD (13.9% and 7.7%,
respectively). Our hypothesis is that these highly nicotine-
dependent smokers tried e-cigarettes for smoking cessa-
tion or to reduce cigarette use, but they continued
smoking or relapsed in a short time. In addition, we
found no differences in the satisfaction according to the
use of the e-cigarettes with or without nicotine. More lon-
gitudinal and qualitative studies are needed to conﬁrm
this hypothesis.
Some studies suggest that e-cigarettes could be
another way to create new nicotine addicts,
29 30 particu-
larly among young people, who may graduate to conven-
tional tobacco products over time. Moreover, the current
advertisements and messages about e-cigarettes in the
media and the social networks, such as twitter, could
increase the experimentation, particularly among the
young and middle aged population.
31–33 The results of
Table 2 Prevalence of current use, past use and experimentation with e-cigarettes according to sex, age, educational level,
smoking status and FTCD in Barcelona, Spain (2013–14).
Current
e-cigarette use
Past
e-cigarette use
Experimentation with
e-cigarettes
% (95% CI) n % (95% CI) % (95% CI)
Overall 736 1.6 (0.7 to 2.5) 2.2 (1.1 to 3.3) 2.7 (1.5 to 3.9)
Sex
Men 336 1.8 (0.4 to 3.2) 3.3 (1.4 to 5.2) 3.0 (1.2 to 4.8)
Women 400 1.5 (0.3 to 2.7) 1.3 (0.2 to 2.4) 2.5 (1.0 to 4.0)
Age (years)
≤44 198 2.0 (0.0 to 4.0) 5.1 (2.0 to 8.2) 6.1 (2.8 to 9.4)
45–64 267 1.9 (0.3 to 3.5) 1.9 (0.3 to 3.5) 3.0 (1.0 to 5.0)
≥65 271 1.1 (0.4 to 3.2) 0.4 (0.1 to 2.1) 0.0 (0.0 to 1.4)
Educational level
Low 161 1.2 (0.3 to 4.4) 0.0 (0.0 to 2.3) 1.9 (0.6 to 5.3)
Intermediate 287 2.4 (0.6 to 4.2) 4.5 (2.1 to 6.9) 2.8 (0.9 to 4.7)
High 288 1.0 (0.4 to 3.0) 1.0 (0.4 to 3.0) 3.1 (1.1 to 5.1)
Smoking status
Never-smoker 298 0.3 (1.6 to 5.6) 0.0 (0.0 to 1.3) 0.0 (0.0 to 1.3)
Former smoker 267 0.7 (0.2 to 2.7) 1.1 (0.4 to 3.3) 2.2 (0.4 to 4.0)
Current smoker 171 5.3 (1.9 to 8.7) 7.6 (3.6 to 11.6) 8.2 (4.1 to 12.3)
FTCD
Low-Medium (0–5) 143 3.5 (0.5 to 6.5) 5.6 (1.8 to 9.4) 7 (2.8 to 11.2)
High (6–10) 28 14.3 (1.3 to 27.3) 17.9 (3.7 to 32.1) 14.3 (1.3 to 27.3)
CI, confidence intervals; FTCD, Fagerström test for cigarette dependence.
4 Martínez-Sánchez JM, et al. BMJ Open 2014;4:e005894. doi:10.1136/bmjopen-2014-005894
Open Accessour study show that 62.5% of ever e-cigarette users pre-
ferred e-cigarettes with nicotine, and a considerable per-
centage of them were young people. However, the
percentage of never-smokers who had ever used the
e-cigarettes is very low (0.3%) and its use was without
nicotine. However, this result should be taken with
caution because of the small sample size in this category.
The main limitation of our study is the potential of par-
ticipation bias due to the attrition of the cohort of partici-
pants. Although there are no statistically signiﬁcant
differences between the people who were followed up
and those lost from the original study according to sex,
age and educational level, our ﬁnal sample overestimated
the older people compared with the distribution of popu-
lation in Barcelona. For this reason, the prevalence of
e-cigarette use might be underestimated in our study
because young people, particularly younger smokers, are
those who most used e-cigarettes. Moreover, we con-
ducted the study only in the city of Barcelona and the val-
idity to infer the results to the rest of Spain could be
limited. Nevertheless, the baseline sample size was repre-
sentative of the city of Barcelona
56and the ﬁnal sample
size for this analysis was sufﬁcient to estimate the preva-
lence of e-cigarette users, due to the relatively lower
prevalence of ever e-cigarette use in the general popula-
tion.
89According to an expected prevalence of ever
e-cigarette use of 10%, the sample size would be 554 indi-
viduals, with an α error of 5% and a precision of 2.5%.
Another potential limitation is the use of a questionnaire
to collect self-reported information on e-cigarette use
that could be an inherent source of bias. However, this is
the ﬁrst study, to our knowledge, that used a face-to-face
questionnaire with trained interviewers to assess
e-cigarette use in a representative sample of the general
population, thus potentially increasing the internal valid-
ity of our results as compared with internet and other
self-administered surveys.
92 6Additionally, our results
could slightly underestimate the real prevalence of use,
because we only included the term ‘e-cigarette’ in the
questionnaire, and there are other terms associated to
new products in the market. However, this effect may be
limited, because the term ‘e-cigarettes’ is the most
popular in Spain, and products such as ‘hookah pens’ or
‘vape pens’ are scantily marketed. Finally, this is a cross-
sectional study and it is only possible to assess associations
and not causal relationships.
In conclusion, 6.5% of the adult general populations
in Barcelona (Spain) are ever e-cigarette users, and 6
out of 10 of them used devices that deliver nicotine.
According to evidence from other countries, this ﬁgure
could double in coming years among the general popu-
lation
9 as well as in the adolescent and student popula-
tions.
29 34 Furthermore, our results show that current
and ever e-cigarette use was predominant among
current smokers, indicating a dual use pattern, and that
there were very low levels of satisfaction with e-cigarettes.
More investigation is needed on dual use (e-cigarettes
and conventional tobacco) and on users’ satisfaction
with e-cigarette devices, as well as on the effectiveness of
e-cigarettes for smoking cessation and their beneﬁt–risk
balance.
Author affiliations
1Tobacco Control Unit, Cancer Prevention and Control Program, Institut Català
d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain
2Cancer Prevention and Control Group, Institut d’Investigació Biomèdica de
Bellvitge—IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
3Biostatistics Unit, Department of Basic Sciences, Universitat Internacional de
Catalunya, Sant Cugat del Vallès, Barcelona, Spain
4Public Health Advocacy Institute, Northeastern University School of Law,
Boston, Massachusetts, USA
5Department of Clinical Sciences, Universitat de Barcelona, Barcelona, Spain
6Addictions Unit, Institute of Neurosciences, Hospital Clínic de Barcelona—
IDIBAPS, Barcelona, Spain
7Health Plan Directorate, Ministry of Health, Generalitat de Catalunya,
Barcelona, Spain
8Department of Public Health, Universitat de Barcelona, Barcelona, Spain
9Department of Social and Behavioral Sciences, Center for Global Tobacco
Control, Harvard School of Public Health, Boston, Massachusetts, USA
Acknowledgements The authors wish to thank Nuria Quirós for her
contribution to the follow-up of participants by means of the Insurance
Central Registry of Catalonia and Montse Ferré and Lucía Baranda with the
coordination of the filed work operations.
Contributors JMMS and EF conceived the study. MB, MF, EF, ES and JMMS
contributed to the design and coordination of the study. JCMS analysed the
data. JMMS drafted the first manuscript. All authors contributed substantially
to the interpretation of the data and the successive versions of the
manuscript. All authors contributed to the manuscript and approved its final
version. JMMS is the principal investigator of the project.
Funding This project was funded by the Instituto de Salud Carlos III,
Government of Spain (RTICC, RD12/0036/0053 and PI12/01114) and the
Ministry of Universities and Research, Government of Catalonia (grant
2009SGR192).
Competing interests None.
Ethics approval The Research and Ethics Committee of the Bellvitge
University Hospital provided ethical approval for the study protocol.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Etter JF, Bullen C, Flouris AD, et al. Electronic nicotine delivery
systems: a research agenda. Tob Control 2011;20:243–8.
2. Cobb NK, Byron MJ, Abrams DB, et al. Novel nicotine delivery
systems and public health: the rise of the “e-cigarette”. Am J Public
Health 2010;100:2340–2.
3. Ayers JW, Ribisl KM, Brownstein JS. Tracking the rise in popularity
of electronic nicotine delivery systems (electronic cigarettes) using
search query surveillance. Am J Prev Med 2011;40:448–53.
4. Regan AK, Promoff G, Dube SR, et al. Electronic nicotine delivery
systems: adult use and awareness of the ‘e-cigarette’ in the USA.
Tob Control 2013;22:19–23.
5. Fu M, Fernandez E, Martinez-Sanchez JM, et al. Salivary cotinine
concentrations in daily smokers in Barcelona, Spain:
a cross-sectional study. BMC Public Health 2009;9:320.
6. Martinez-Sanchez JM, Fernandez E, Fu M, et al. Assessment of
exposure to secondhand smoke by questionnaire and salivary
Martínez-Sánchez JM, et al. BMJ Open 2014;4:e005894. doi:10.1136/bmjopen-2014-005894 5
Open Accesscotinine in the general population of Barcelona, Spain (2004-2005).
Prev Med 2009;48:218–23.
7. Fagerstrom K. Determinants of tobacco use and renaming the FTND
to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res
2012;14:75–8.
8. European Commision. Attitudes of Europeans towards tobacco
(Special Eurobarometer 385). http://ec.europa.eu/health/tobacco/
eurobarometers/index_en.htm (accessed 20 May 2014)
9. King BA, Alam S, Promoff G, et al. Awareness and ever-use of
electronic cigarettes among U.S. adults, 2010–2011. Nicotine Tob
Res 2013;15:1623–7.
10. Xarxa Catalana d’Hospitals sense fum. Statement of the Catalan
Network of Smoke-free Hospitals and the Network of Primary Care
on the use of electronic cigarettes in health centers. Barcelona, 30
Jul 2013. http://tobaccorelated.files.wordpress.com/2013/08/
statement_ecigs.pdf (accessed 28 Jul 2014)
11. Douptcheva N, Gmel G, Studer J, et al. Use of electronic cigarettes
among young Swiss men. J Epidemiol Community Health
2013;67:1075–6.
12. Goniewicz ML, Zielinska-Danch W. Electronic cigarette use among
teenagers and young adults in Poland. Pediatrics 2012;130:e879–85.
13. Adkison SE, O’Connor RJ, Bansal-Travers M, et al. Electronic
nicotine delivery systems: international tobacco control four-country
survey. Am J Prev Med 2013;44:207–15.
14. Cobb NK, Abrams DB. E-cigarette or drug-delivery device?
Regulating novel nicotine products. N Engl J Med 2011;365:193–5.
15. Fairchild AL, Bayer R, Colgrove J. The renormalization of smoking?
E-cigarettes and the tobacco “endgame”. N Engl J Med
2014;370:293–5.
16. Farsalinos K, Voudris V. It is preferable for surgical patients to use
e-cigarettes rather than smoke cigarettes. BMJ 2014;348:g1961.
17. Kmietowicz Z. E-cigarettes are “gateway devices” for smoking
among young people, say researchers. BMJ 2014;348:g2034.
18. Auf R. Electronic cigarettes and smoking cessation: a quandary?
Lancet 2014;383:408.
19. Bialous SA, Sarma L. Electronic cigarettes and smoking cessation:
a quandary? Lancet 2014;383:407–8.
20. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes and
smoking cessation: a quandary?—Authors’ reply. Lancet
2014;383:408–9.
21. Doyle C, Patterson S, Scott J. Electronic cigarettes and smoking
cessation: a quandary? Lancet 2014;383:408.
22. Hajek P. Electronic cigarettes for smoking cessation. Lancet
2013;382:1614–16.
23. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for
smoking cessation: a randomised controlled trial. Lancet
2013;382:1629–37.
24. Etter JF, Bullen C. A longitudinal study of electronic cigarette users.
Addict Behav 2014;39:491–4.
25. Polosa R, Caponnetto P, Morjaria JB, et al. Effect of an electronic
nicotine delivery device (e-Cigarette) on smoking reduction and
cessation: a prospective 6-month pilot study. BMC Public Health
2011;11:786.
26. Pearson JL, Richardson A, Niaura RS, et al. e-Cigarette awareness,
use, and harm perceptions in US adults. Am J Public Health
2012;102:1758–66.
27. Grana RA, Ling PM, Benowitz N, et al. Electronic cigarettes.
Circulation 2014;129:e490–2.
28. Pepper JK, Brewer NT. Electronic nicotine delivery system
(electronic cigarette) awareness, use, reactions and beliefs:
a systematic review. Tob Control 2014;23:375–84.
29. Dutra LM, Glantz SA. Electronic cigarettes and conventional
cigarette use among US adolescents: a cross-sectional Study.
JAMA Pediatr 2014 (in press) doi:10.1001/jamapediatrics.2013.5488
30. Lee S, Grana RA, Glantz SA. Electronic cigarette use among
Korean adolescents: a cross-sectional study of market penetration,
dual use, and relationship to quit attempts and former smoking.
J Adolesc Health 2014;54:684–90.
31. Pepper JK, Emery SL, Ribisl KM, et al. Effects of advertisements
on smokers’ interest in trying e-cigarettes: the roles of product
comparison and visual cues. Tob Control 2014;23(Suppl 3):iii31–6.
32. Huang J, Kornfield R, Szczypka G, et al. A cross-sectional
examination of marketing of electronic cigarettes on Twitter. Tob
Control 2014;23(Suppl 3):iii26–30.
33. de Andrade M, Hastings G, Angus K. Promotion of electronic
cigarettes: tobacco marketing reinvented? BMJ 2013;347:f7473.
34. Corey C, Wang B, Johnson SE, et al. Centers for Disease Control
and Prevention. Notes from the field: electronic cigarette use among
middle and high school students—United States, 2011–2012.
MMWR Morb Mortal Wkly Rep 2013;62:729–30.
6 Martínez-Sánchez JM, et al. BMJ Open 2014;4:e005894. doi:10.1136/bmjopen-2014-005894
Open Access